Filing Flows › DexCom (DXCM) › Gross margin
DexCom (DXCM) gross margin by quarter
DexCom's gross margin was 64.3% in Q3 2026 (third quarter 2026), +0.9 pts from Q2 2026. Over the last 7 quarters it ranged from 56.9% (Q1 2025) to 64.3% (Q3 2026).
| Quarter | Gross margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 64.3% | +0.9 pts | +3.8 pts |
| Q2 2026 | 63.4% | +0.5 pts | +3.9 pts |
| Q1 2026 | 62.9% | +0.0 pts | +6.1 pts |
| Q4 2025 | 62.9% | +2.5 pts | — |
| Q3 2025 | 60.5% | +1.0 pts | — |
| Q2 2025 | 59.5% | +2.7 pts | — |
| Q1 2025 | 56.9% | — | — |
Q3 2026 at a glance
DexCom, Q3 2026: revenue $1.3B (+11% year over year), operating margin 24.3%, net earnings $275M, operating cash flow $326M. The chart follows the revenue to costs, profit and cash.
Questions
What is DexCom's gross margin?
DexCom's gross margin was 64.3% in Q3 2026 (third quarter 2026), +0.9 pts from Q2 2026.
How has DexCom's gross margin changed?
Over the last 7 quarters it ranged from 56.9% (Q1 2025) to 64.3% (Q3 2026).